We are live on ! Find out more
GG

Gofen & Glossberg Portfolio holdings

AUM $3.89B
1-Year Est. Return 11.97%
This Fund
S&P 500
This Quarter Est. Return
+4.81%
1 Year Est. Return
-11.97%
3 Year Est. Return
+36.4%
5 Year Est. Return
+73.95%
10 Year Est. Return
AUM
$1.94B
AUM Growth
+$94.8M
Cap. Flow
+$11M
Cap. Flow %
0.56%
Top 10 Hldgs %
24.55%
Holding
540
New
41
Increased
103
Reduced
174
Closed
11

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$1.69M
2
ORCL icon
Oracle
ORCL
+$1.57M
3
XOM icon
ExxonMobil
XOM
+$1.33M
4
TEVA icon
Teva Pharmaceuticals
TEVA
+$1.08M
5
MSFT icon
Microsoft
MSFT
+$975K

Sector Composition

Rank Sector Weight
1 Healthcare 15.04%
2 Industrials 11.78%
3 Technology 11.54%
4 Consumer Staples 11.09%
5 Financials 10.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
HPQ icon
401
HP
HPQ
$24.3B
-12,001
Closed -$135K
VMI icon
402
Valmont Industries
VMI
$9.61B
-1,500
Closed -$215K
VO icon
403
Vanguard Mid-Cap ETF
VO
$107B
-11,432
Closed -$272K
XEL icon
404
Xcel Energy
XEL
$50.4B
-3,005
Closed -$85K
EXAM
405
DELISTED
EXAMWORKS GROUP INC COM STK (DE)
EXAM
-13,666
Closed -$290K
KWK
406
DELISTED
QUICKSILVER RESOURCES INC
KWK
$0 ﹤0.01%
37
DYX
407
DELISTED
DIASYS CORPORATION
DYX
$0 ﹤0.01%
20,000

Similar funds

Gofen & Glossberg's Q3 2013 Portfolio in Review

As of Q3 2013, Gofen & Glossberg held 540 positions worth $1.94B, up 5.1% from $1.85B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Gofen & Glossberg's Q3 2013 filing shows 41 new, 103 increased, 174 reduced and 11 closed positions. Its largest new stake was US AIRWAYS GROUP INC.: 159,450 shares worth $3.02M. The largest sale was Celgene Corp, an estimated $1.69M.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 15% a quarter earlier, followed by Industrials and Technology.

  • Gofen & Glossberg's largest Q3 2013 buy was US AIRWAYS GROUP INC.: 159,450 shares worth $3.02M.
  • Gofen & Glossberg added most to Occidental Petroleum in Q3 2013, an estimated $5.28M increase.
  • Gofen & Glossberg's biggest Q3 2013 reduction was Celgene Corp, cutting an estimated $1.69M.
  • Gofen & Glossberg fully exited EQT Corp in Q3 2013, selling an estimated $391K.
  • Gofen & Glossberg's ten largest holdings make up 25% of its $1.94B portfolio in Q3 2013.
  • Gofen & Glossberg opened 41 new positions and closed 11 in Q3 2013.
  • Gofen & Glossberg's portfolio value rose 5.1% quarter-over-quarter to $1.94B.

Based on Gofen & Glossberg's 13F filing for Q3 2013, filed 10 Oct 2013.